Nemaura Medical Inc.
NMRD
$0.0002
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 18.56% | 31.01% | 10.91% | -1.85% | -5.47% |
| Total Depreciation and Amortization | 35.29% | 56.06% | 51.57% | 93.21% | 111.50% |
| Total Amortization of Deferred Charges | -108.41% | -112.17% | -90.87% | -71.93% | -8.85% |
| Total Other Non-Cash Items | 109.48% | 11.36% | 231.29% | 721.45% | 379.71% |
| Change in Net Operating Assets | 46.85% | -3.99% | -81.16% | -1,075.23% | -3,900.66% |
| Cash from Operations | -16.08% | -27.05% | -19.32% | -29.95% | -44.25% |
| Capital Expenditure | 55.49% | 50.36% | 10.68% | 21.92% | -4.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 105.09% | 108.29% | 65.67% | 84.83% |
| Cash from Investing | 65.61% | 65.56% | 54.81% | 43.63% | 55.24% |
| Total Debt Issued | 38.30% | 38.30% | -100.00% | -- | -76.50% |
| Total Debt Repaid | 17.27% | 31.57% | 41.94% | 17.14% | -104.03% |
| Issuance of Common Stock | 179.71% | 169.15% | 169.15% | 38.00% | -2.84% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,479.01% | -1,352.17% | -1,352.17% | -1,352.17% | 96.12% |
| Cash from Financing | 143.05% | 155.98% | 81.74% | 132.69% | -141.24% |
| Foreign Exchange rate Adjustments | 80.98% | 110.70% | 42.81% | -155.93% | -445.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 54.13% | 65.59% | 34.93% | 45.85% | -294.22% |